Product code QUR— Ophthalmic
Essilor® Stellest®
- Classification name
- Prescription Spectacle Lenses To Reduce The Progression Of Myopia
- Device class
- Class 2
- Regulation
- 21 CFR 886.5845
- Advisory panel
- Ophthalmic
- Total cleared
- 1
- First cleared
- Most recent
FDA classification definition
“Prescription spectacle lenses to reduce the progression of myopia consist of spectacle lenses with additional physical optical design lens elements. In addition to optical correction of myopic refractive error, these lenses are intended to be used by children who have myopia to reduce the rate of myopia progression. The lenses are mounted within a spectacle frame classified under § 886.5842.”
Market context for product code QUR
FDA has cleared device under product code QUR, all in 2025, filed by 1 applicant company. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Top applicants under product code QUR
Recent clearances under product code QUR
Data sourced from openFDA. This site is unofficial and independent of the FDA.